-+ 0.00%
-+ 0.00%
-+ 0.00%

DOGWOOD THERAPEUTICS: TO SUBMIT END OF HALNEURON PHASE 2 SUMMARY, MANUFACTURING PLANS & PHASE 3 CLINICAL DEVELOPMENT PLANS TO FDA TOWARDS END OF 2026

Reuters·01/20/2026 13:34:57

Please log in to view news